A New Look at Trigger Point Injections by Wong, Clara S. M. & Wong, Steven H. S.
Hindawi Publishing Corporation
Anesthesiology Research and Practice
Volume 2012, Article ID 492452, 5 pages
doi:10.1155/2012/492452
Review Article
A New Look at Trigger Point Injections
Clara S. M. Wong and Steven H.S. Wong
Department of Anaesthesiology, Queen Elizabeth Hospital, 30 Gascoigne Road, Kowloon, Hong Kong
Correspondence should be addressed to Steven H. S. Wong, wonghss@ha.org.hk
Received 31 May 2011; Revised 28 July 2011; Accepted 30 July 2011
Academic Editor: Andrea Trescot
Copyright © 2012 C. S. M. Wong and S. H. S. Wong. This is an open access article distributed under the Creative Commons
Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is
properly cited.
Trigger point injections are commonly practised pain interventional techniques. However, there is still lack of objective diagnostic
criteria for trigger points. The mechanisms of action of trigger point injection remain obscure and its eﬃcacy remains
heterogeneous. The advent of ultrasound technology in the noninvasive real-time imaging of soft tissues sheds new light on
visualization of trigger points, explaining the eﬀect of trigger point injection by blockade of peripheral nerves, and minimizing the
complications of blind injection.
1.Introduction
Myofascial pain syndrome is a common, painful musculo-
skeletal disorder characterized by the presence of trigger
points. They have been implicated in patients with headache,
neck pain, low back pain, and various other musculoskeletal
and systemic disorders [1–4]. The prevalence of myofascial
trigger points among patients complaining of pain anywhere
in the body ranged from 30% to 93% [5]. Although the most
importantstrategyintreatmentofmyofascialpainsyndrome
is to identify the etiological lesion that causes the activation
of trigger points and to treat the underlying pathology [6],
trigger point injections are still commonly practised pain
interventional technique for symptomatic relief.
Despite the popularity of trigger point injections, the pa-
thophysiology of myofascial trigger points remains unclear.
Localization of a trigger point is often based on the physi-
cian’s examination. However, such physical examination is
often unreliable. Lack of objective clinical measurements has
also been a barrier for critically evaluating the eﬃcacy of the
therapeutic methods.
Ultrasound is used extensively for noninvasive real-time
imaging of soft tissues including muscle, nerve, tendon,
fascia, and blood vessels. With the advent of portable ultra-
sound technology, ultrasound is now commonly employed
in the ﬁeld of regional analgesia. In this paper, we will look
at the potential application of ultrasound in trigger point in-
jections.
2. Diagnosisof Trigger Points
Physician’s sense of feel and patient expressions of pain upon
palpation are the most commonly used method to localize
a trigger point. The most common physical ﬁnding is pal-
pation of a hypersensitive bundle or nodule of muscle ﬁbre
of harder than normal consistency. The palpation will elicit
pain over the palpated muscle and/or cause radiation of pain
towardsthezoneofreferenceinadditiontoatwitchresponse
[7].
In myofascial pain syndrome, trigger points have been
classiﬁedinto activeor latent. In anactive triggerpoint, there
is an area of tenderness at rest or on palpation, a taut band of
muscle, a local twitch response, and referred pain elicited by
ﬁrm compression similar to the patient’s complaint. Latent





satellite. An active key trigger point in one muscle can induce
an active satellite trigger point in another muscle. Inactiva-
tion of the key trigger point often also inactivates its satellite
trigger point without treatment of the satellite trigger point
itself [7].
Thediagnosisoftriggerpointsdependsverymuchonthe
subjective experience of the physician. Pressure algometry
has been used to quantify the sensitivity of trigger points.2 Anesthesiology Research and Practice
A hand-held pressure meter with a 1cm2 rubber disc at-
t a c h e dt oaf o r c eg a u g ec a l i b r a t e du pt o1 0k gi sa p p l i e do v e r
a trigger point to measure its pain threshold [8]. However,
this method is not commonly employed clinically, and there
havenotbeenanyimagingcriteriaforthediagnosisoftrigger
points.
3. Pathophysiology of TriggerPoints
Trigger points are deﬁned as palpable, tense bands of skeletal
muscle ﬁbres. They can produce both local and referred pain
when compressed.
The local pain could be explained by the tissue ischemia
resulting from prolonged muscle contraction with accumu-
lation of acids and chemicals such as serotonin, histamine,
kinins, and prostaglandins [9]. These changes are fed into
a cycle of increasing motor or sympathetic activity and can
lead to increased pain. A painful event can sustain itself once
a cycle is established even after the initial stimulus has been
removed [10].
T h ep a t h o g e n e s i so ft r i g g e rp o i n t si sp r o b a b l yr e l a t e d
to sensitized sensory nerve ﬁbres (nociceptors) associated
withdysfunctionalendplates[11].Infact,endplatenoisewas
foundtobesigniﬁcantlymoreprevalentinmyofascialtrigger
points than in sites that were outside of a trigger point but
still within the endplate zone [12].
Studies have found that development of trigger points is
dependent on an integrative mechanism in the spinal cord.
When the input from nociceptors in an original receptive
ﬁeld persists (pain from an active trigger point), central sen-
sitization in the spinal cord may develop, and the receptive
ﬁeld corresponding to the original dorsal horn neuron may
be expanded (referred pain). Through this mechanism, new
“satellite trigger points” may develop in the referred zone of
the original trigger point [11].
4. Mechanisms of Action of Trigger
Point Injections
Noninvasive measures for treatment of trigger points in-
clude spray and stretch, transcutaneous electrical stimula-
tion, physical therapy, and massage. Invasive treatments in-
clude injections with local anaesthetics, corticosteroids, or
botulinum toxin, or dry needling [13–18].
Hong reported that with either lidocaine injection or dry
needling of trigger points, the patients experienced almost
complete relief of pain immediately after injection if local
twitch responses were elicited. On the other hand, they ex-
perienced only minimal relief if no such response occurred
during injection. Hong has suggested that nociceptors (free
nerve endings) are encountered and blocked during trigger
point injection if local twitch response can be elicited [19].
The mechanism of action of trigger point injections is
thought to be disruption of the trigger points by the me-
chanical eﬀect of the needle or the chemical eﬀect of the
agents injected, resulting in relaxation and lengthening of
the muscle ﬁbre. The eﬀect of the injectate may include
local vasodilation, dilution, and removal of the accumulated
nociceptive substrates. Botulinum toxin A has been used to
block acetylcholine release from the motor nerve ending and
subsequently relieve the taut band [6].
While the relief of local pain could easily be explained by
the relaxation of the muscle ﬁbre, the relief of referred pain
could not be explained without attributing it to a peripheral
nerve blockade. However, little has been said in the literature
regarding the mechanism of trigger point injection in this
respect.
5. Could the Application of Ultrasound
Solve the Mystery of Trigger Points?
5.1. Direct Visualization of Trigger Points. As mentioned
above, the most common physical ﬁnding of a trigger point
is palpation of a hypersensitive bundle or nodule of muscle
ﬁbre of harder than normal consistency. Attempts to conﬁrm
the presence of myofascial trigger points using imaging have
been demonstrated by magnetic resonance elastography
[20]. For ultrasound, earlier studies have failed to ﬁnd any
correlation between physical ﬁndings and diagnostic ultra-
sound [21]. This may be attributed to poorer quality of ul-
trasound imaging in earlier dates.
Recently, Sikdar et al. have tried to use ultrasound to
visualize and characterize trigger points. They found that
trigger points appeared as focal, hypoechoic regions of el-
liptical shape, with a size of 0.16cm [22]. This is promising
as ultrasound can provide a more objective diagnosis of
trigger point. Even if visualization of individual trigger point
is diﬃcult due to the small size, some advocate the use of
ultrasound to guide proper needle placement in muscle
tissue and to avoid adipose or nonmusculature structures
during trigger point injections [23].
5.2. Injection of Peripheral Nerves. Trigger point injections
have been implicated in patients with headache, low back
pain, and various other musculoskeletal and systemic disor-
ders. Some of these injections may involve injectate depo-
sition directly to the nerves supplying the region. Indeed,
entrapment, compression, or irritation of the sensory nerves
of local regions has been implicated in various conditions.
5.2.1. Greater Occipital Nerve. Entrapment of the greater oc-
cipital nerve is often implicated as the cause of cervicogenic
headache, and the characteristic occipital headache can be
reproduced by ﬁnger pressure over the corresponding occip-
ital nerve over the occipital ridge [3, 24–26]. This referral
pattern of pain coincides with that of the properties of a
trigger point, and it could explain the mechanism of referred
pain for trigger points.
Simons has considered that the eﬀect of greater occipital
nerve injection is due to the release of the entrapment by
relaxation of semispinalis muscle [7]. However, injection of
local anaesthetics with or without steroid over the occipital
nerve has been found to result in alleviation of occipital
headache [27]. In migraine headaches, local injection of




ade of greater occipital nerve. The classical distal block tech-
nique involves placing the transducer at the superior nuchal
line, while for the new proximal approach, the transducer is
placed at the level of C2, and the greater occipital nerve lies
superﬁcial to the obliquus capitis inferior muscle [28, 29].
5.2.2. Abdominal Cutaneous Nerve. Kuan et al. showed that
local injection of anaesthetics or steroid can treat some pa-
tients with lower abdominal pain presenting with trigger
points in the abdomen, thus avoiding diagnostic laparoscopy
and medications [30].
Trigger points over the abdominal wall may in fact be
entrapped cutaneous nerves. Peripheral nerve entrapment
(e.g., ilioinguinal-iliohypogastric nerves, thoracic lateral cu-
taneous nerve) has been suggested to cause lower abdominal
pain [31, 32].
Ultrasound-guided blocks for ilioinguinal and iliohy-
pogastric nerves have been practised widely in anaesthesia
[33–35]. Recently, ultrasound-guided transversus abdominis
plane (TAP) block is also commonly used to provide postop-
erative pain relief for patients undergoing laparotomy [35–
38].
Byplacingtheultrasoundprobeabout5cmcranialtothe
anterior superior iliac spine, the ilioinguinal and iliohypo-
gastric nerves can be found between the transverse abdomi-
nal and the internal oblique muscle [39]. For TAP block, the
transducer can be placed in a transverse plane between the
iliaccrestandtheanterioraxillaryline.Localanaestheticscan
be deposited between the transversus abdominis muscle and
the internal oblique muscle [40].
5.2.3. Dorsal Ramus of Spinal Nerve. Low back pain is a com-
mon chronic pain syndrome; however, in most cases, a spe-
cific diagnosis cannot be established. Trigger point injections
have been found to relieve myofascial low back pains.
However, there has been lack of evidence in the literature
to support its eﬃcacy. This could be attributed to the het-
erogeneity in the diagnosis and technique of localization of
trigger points in low back pain. Most of the studies employed
subjective localization of trigger points, and the techniques
of localization and injection of trigger points were not well
described.
Miyakoshi et al. demonstrated that CT-guided total dor-
sal ramus block was eﬀective in the treatment of chronic low
back pain in a group of patients with overlapping facet syn-
drome with myofascial syndrome with pain originating from
myofascial structure, facet joint, or both [41]. They dem-
onstrated that a single injection of a larger volume of local
anaesthetics over the conventional target point for medial
branch block, which was the junction of the L5 superior ar-
ticular process and the transverse process, was eﬀective to
block the medial, intermediate, and lateral branches of the
lumbar dorsal ramus, with signiﬁcantly better pain reduc-
tion compared to conventional trigger point injection. The
ﬁndings in this study shed light to the possibility of relief of
myofascial pain syndrome by a single nerve injection. It may
explain the poor results of pure intramuscular injections in
controlled studies, in contrast to the better results with un-
controlled studies and case reports, in which some of the
resultsmaybeattributabletoaccidentalnerveinjectionusing
the conventional blind injection techniques.
For ultrasound-guided medial branch block, the trans-
ducer is ﬁrst placed longitudinally to ﬁnd the respective
transverse process and localize the lumbar level. Then the
transducer can be rotated into a transverse plane to delineate
the transverse process and the superior articular process of
the adjacent facet joint. The bottom of the groove between
the lateral surface of the superior articular process and the
cephalad margin of the respective transverse process was
deﬁned as the target site [42].
Ultrasound-guided technique may be adapted to per-
form injection of the lower back, targeting at the dorsal rami
of the lumbar spinal nerves to increase the eﬃcacy of in-
jection.
5.2.4. Lumbar Plexus. There have been case reports on the
use of trigger point injection for treatment of pain that was
remote from the site of trigger points. Interestingly, Iguchi et
al. used trigger point injection for the amelioration of renal
colic. In their paper, they described the injection technique
as follows. Trigger points were located over the paraspinal
region at around L3 level. A long needle (23-gauge 6cm)
was inserted deep into the trigger points, and 5–10mL of
1% lignocaine was injected [43]. Such injection was in fact
into the psoas muscle, and the eﬀect could be attributed to a
lumbar plexus block.
Lumbar plexus block with ultrasound guidance has been
described. A curved transducer can be placed in the trans-
verse plane at L2–L4 level for the lumbar plexus block. This
transverse view should show the psoas muscle without the
transverse process. The target of the needle tip is within the
posterior 1/3 of the psoas muscle bulk [40].
5.2.5. Pudendal Nerve. Langford et al. reported the eﬀective
use of levator ani trigger point injection in the treatment of
chronic pelvic pain. Trigger points were identiﬁed by manual
intravaginal palpation, and the trigger points were injected
with a large volume (up to about 20mL) of a mixture of local
anesthetics and depot steroid. The eﬀect of such injection
might in fact be caused by the concomitant pudendal nerve
block [44].
Pudendal nerve blockade with ultrasound guidance can
be performed via the transgluteal approach. The probe is
placed transverse to the posterior superior iliac spine and
moved caudally until the piriformis muscle is seen. The
probe is then moved further caudad to identify the ischial
spine, in which the pudendal nerve will be seen lying medial
to the pudendal artery [29].
6. Other Advantagesof Ultrasound
inTriggerPointInjections
Trigger point injections are commonly performed in clinics
as an outpatient procedure. Serious complications, although4 Anesthesiology Research and Practice
of rare occurrence, have been reported (e.g., pneumothorax,
haematoma,intravascularinjectionoflocalanaesthetics,and
intrathecalinjections)[45].Directvisualizationofsurround-
ing soft tissues and important structures can reduce the risk
of such complications. Moreover, ultrasound allows real-
time imaging of the spread of the injectate around the rele-




fectiveness of trigger point injection remains heterogenous.
There is so far no strong evidence for the eﬀectiveness of
triggerpointinjections,andmanyphysiciansconsidertrigger
point injections a little more than, if not equivalent to, pla-
cebo eﬀects.
With the advancement of ultrasound technology, the
quality of scans for soft tissues and musculature has im-
proved dramatically. Future studies may focus on more ob-
jective diagnostic criteria of trigger points using ultrasound
imaging. For the technique of trigger point injections, real-
time visualization of trigger points, relaxation of locally con-
tracting muscles, and visualization of surrounding tissues or
important structures may improve the outcome and mini-
mize complications of such treatments.
Moreover, eﬃcacy of some of the trigger point injections
traditionally performed may be related to some kind of pe-
ripheral nerve blocks, the implication which is yet to be ex-
plored.
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